Cleared Traditional

K182907 - SPY Elite Intraoperative Perfusion Asse...

K182907 is the FDA 510(k) clearance for SPY Elite Intraoperative Perfusion Asse... by Novadaq Technologies Ulc. (Now A Part of Stryker). It is a Class 2 General & Plastic Surgery device (product code IZI) cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K182907 · Novadaq Technologies Ulc. (Now A Part of Stryker) · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
98d
Days
Class 2
Risk

K182907 is an FDA 510(k) clearance for the SPY Elite Intraoperative Perfusion Assessment System. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Novadaq Technologies Ulc. (Now A Part of Stryker) (Burnaby, CA). The FDA issued a Cleared decision on January 23, 2019 after a review of 98 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 892.1600 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Novadaq Technologies Ulc. (Now A Part of Stryker) devices

Submission Details

510(k) Number K182907 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 2018
Decision Date January 23, 2019
Days to Decision 98 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 115d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 97
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K182907.
DIR 800
K202391 · Aesculap, Inc. · Jan 2021
Asimov-MKS Imaging System
K192761 · Onlume, Inc. · Jan 2020
SURGICAL MICROSCOPE SYSTEM ORBEYE with IR
K190772 · Olympus Medical Systems Corp. · Oct 2019
GLOW800
K181537 · Leica Microsystems (Schweiz) AG · Sep 2018
CAAS Workstation
K180019 · Pie Medical Imaging BV · May 2018
YELLOW 560 Fluorescence Module
K162991 · Carl Zeiss Meditec, AG · Jul 2017